Table 1.
Clinical data from all hospital sites and additional samples collected from 26 patients with confirmed COVID-19 infection as notified to DHHS.
| RMH | Monash | Austin | Across all hospitals | Additional samples* | |
|---|---|---|---|---|---|
| Staff performing test (n) | 101 | 6 | 16 | 123 | N/A |
| Total participants (n) | 899 | 528 | 991 | 2,418 | 26 |
| Excluded (n) | 3 | 1 | 1 | 5 | 4 |
| Total included (n) | 896 | 527 | 990 | 2413 | 22 |
| Median age (range) | 32 (16-97) | 35 (5-93) | 36 (1-93) | 35 (1-97) | 40 (18-73) |
| Male sex (%) | 397 (44.3%) | 268 (50.9%) | 401 (40.5%) | 1,066 (44.2%) | 8 (36.4%) |
| Asymptomatic (%) | 10 (1.1%) | 36 (6.8%) | 78 (7.9%) | 124 (5.1%) | 0 (0%) |
| Median days of symptoms (range) | 2 (0-22) | 2 (0-14) | 1 (0-36) | 2 (0-36) | 5 (1-33) |
| Positive RT-PCR result (%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | N/A |
| Positive Abbott PanBioTM COVID-19 Ag result (%) | 0 (0%) | 1 (0.2%) | 0 (0%) | 1 (0.04%) | 17 (77.3%) |
⁎
Additional clinical samples collected from participants with known COVID-19, as reported to the Victorian DHHS, to assist with test validation. Note that 4/26 participants were negative by RT-PCR at the time of Abbott Panbio testing. Abbreviations: n; number, RMH; Royal Melbourne Hospital, RT-PCR; reverse-transcription polymerase chain reaction.